|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquired
|
gptkb:Merck_Generics
gptkb:Roxane_Laboratories
|
|
gptkbp:acquisition
|
gptkb:Merck_Generics
gptkb:West-Ward_Pharmaceuticals
gptkb:Roxane_Laboratories
Boehringer Ingelheim's generic business
Merck Generics in 2014
Roxane Laboratories in 2015
West-Ward Pharmaceuticals in 2016
|
|
gptkbp:awards
|
Top 100 Companies in the Arab World
Best Pharmaceutical Company in Jordan
|
|
gptkbp:categories
|
biologics
injectables
liquid formulations
oral solids
|
|
gptkbp:clinical_trial
|
ongoing
|
|
gptkbp:community_programs
|
scholarships
health education
volunteer initiatives
|
|
gptkbp:employees
|
over 7,000
|
|
gptkbp:financial_performance
|
publicly traded
market capitalization over $2 billion
|
|
gptkbp:focus
|
biologics
injectable medications
oral medications
|
|
gptkbp:founded
|
gptkb:1978
|
|
gptkbp:founded_by
|
Samir Aboulatta
|
|
gptkbp:founded_in
|
gptkb:1978
Samir Aboulatta
|
|
gptkbp:founder
|
gptkb:Samih_Darwazah
|
|
gptkbp:global_presence
|
distribution networks
manufacturing facilities in multiple countries
|
|
gptkbp:has_part
|
manufacturing facilities
distribution networks
research and development centers
|
|
gptkbp:has_product
|
injectable medications
over-the-counter products
oral medications
|
|
gptkbp:headquartered_in
|
gptkb:London
|
|
gptkbp:headquarters
|
gptkb:London,_United_Kingdom
gptkb:Amman,_Jordan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hikma Pharmaceuticals
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:investment
|
research facilities
technology upgrades
expansion in emerging markets
|
|
gptkbp:is_displayed_in
|
gptkb:LSE
|
|
gptkbp:is_known_for
|
affordable medications
specialty pharmaceuticals
high-quality generic drugs
|
|
gptkbp:leadership
|
board of directors includes industry experts
CEO is Siggi Olafsson
|
|
gptkbp:market
|
gptkb:Europe
gptkb:Middle_East
gptkb:Asia
gptkb:North_Africa
gptkb:North_America
gptkb:United_States
Middle East and North Africa
|
|
gptkbp:market_cap
|
approximately $3 billion (2021)
|
|
gptkbp:offers
|
branded medications
generic medications
|
|
gptkbp:operates_in
|
gptkb:Middle_East
gptkb:North_Africa
gptkb:United_States
over 50 countries
|
|
gptkbp:partnership
|
gptkb:Incyte_Corporation
gptkb:Eli_Lilly
gptkb:GSK
gptkb:Johnson_&_Johnson
gptkb:Zymeworks
gptkb:Takeda_Pharmaceutical_Company
gptkb:Mylan
gptkb:Astra_Zeneca
gptkb:local_universities
gptkb:Sanofi
gptkb:Boehringer_Ingelheim
gptkb:Bristol-Myers_Squibb
gptkb:FDA
gptkb:World_Health_Organization
gptkb:Baxter_International
gptkb:Pfizer
gptkb:Regeneron_Pharmaceuticals
gptkb:Moderna
gptkb:Teva_Pharmaceuticals
gptkb:Biogen
gptkb:Merck_&_Co.
gptkb:Roche
gptkb:Mirati_Therapeutics
gptkb:Amgen
gptkb:Blueprint_Medicines
gptkb:Gilead_Sciences
gptkb:Sandoz
gptkb:Aprea_Therapeutics
gptkb:Astellas_Pharma
gptkb:Vertex_Pharmaceuticals
gptkb:Sierra_Oncology
gptkb:Abb_Vie
gptkb:Celgene
gptkb:Illumina
gptkb:Cure_Vac
gptkb:Novartis
gptkb:Nant_Kwest
research institutions
various healthcare organizations
|
|
gptkbp:products
|
branded medications
generic medications
|
|
gptkbp:regulatory_compliance
|
FDA approved
EMA approved
|
|
gptkbp:research_and_development
|
focus on complex generics
focus on injectable products
|
|
gptkbp:research_areas
|
oncology
central nervous system
pain management
cardiovascular
anti-infectives
|
|
gptkbp:revenue
|
$1.5 billion (2020)
|
|
gptkbp:social_responsibility
|
gptkb:healthcare_access
education initiatives
disaster relief efforts
|
|
gptkbp:stock_exchange
|
gptkb:London_Stock_Exchange
|
|
gptkbp:stock_symbol
|
HIK
|
|
gptkbp:subsidiary
|
gptkb:Hikma_Egypt
gptkb:Hikma_Jordan
gptkb:Hikma_USA
gptkb:Hikma_Pharmaceuticals_USA_Inc.
Hikma Pharmaceuticals Jordan
|
|
gptkbp:sustainability_initiatives
|
community engagement
employee welfare
environmental responsibility
|
|
gptkbp:bfsParent
|
gptkb:Pfizer
gptkb:Takeda
|
|
gptkbp:bfsLayer
|
4
|